Therefore, the significantly elevated CRP may reflect the severity of inflammation, whereas lymphopenia is associated with suppressed immune function and adverse outcomes of COVID-19 patients, and CLR may be more sensitive in capturing the early part of the inflammatory cascade than other biomarkers as previously reported (19, 21, 26–28). This evidence concerns the gene CRP and lymphopenia.